-

Wolters Kluwer Names Chris Sullivan Vice President Commercial Segment for Clinical Effectiveness

WALTHAM, Mass.--(BUSINESS WIRE)--Wolters Kluwer, Health today announced that Christopher Sullivan has been appointed as Vice President and General Manager of the Commercial Segment for Clinical Effectiveness.

In his 11 years at Wolters Kluwer, Sullivan has held a range of leadership positions in strategy, product management, pricing, and strategic partnerships. Most recently he served as Vice President and General Manager of the Transactional & Retirement Portfolio in Wolters Kluwer’s Legal & Regulatory division, where he oversaw a portfolio of SaaS solutions and expert content serving legal and compliance professionals.

In his new role, Sullivan will lead the Commercial Segment with responsibility for setting strategy and driving growth of its clinical decision support (CDS) solutions including Medi-Span®, Lexicomp®, UpToDate® and Emmi®. The segment provides expert content and workflow tools to professionals in the pharmacy, digital health technology, and commercial payer markets. Sullivan reports to Greg Samios, President and CEO of Clinical Effectiveness, Wolters Kluwer, Health.

“Expanding our footprint in the commercial market is a critical part of our overall strategy,” said Samios. “With his strong background and proven results at Wolters Kluwer, I am confident that Chris will scale our commercial footprint as we accelerate development of impactful solutions for our customers.”

“I’m honored to lead the Commercial Segment as we ramp up investment in the business,” said Sullivan. “These are pivotal times in healthcare—our portfolio is the lifeblood of clinicians worldwide, and we are committed to helping our clients achieve better outcomes at greater speed.”

Prior to joining Wolters Kluwer, Sullivan held a variety of operations management roles at DHL. He earned an MBA from Fordham University and a BS from the United States Military Academy at West Point.

About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer reported 2020 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,200 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.

For more information, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.

Contacts

Media:
André Rebelo
Sr. Global Public Relations Manager
Wolters Kluwer Health
+1 (781) 392-2411
andre.rebelo@wolterskluwer.com

Wolters Kluwer Health

AEX:WKL

Release Versions

Contacts

Media:
André Rebelo
Sr. Global Public Relations Manager
Wolters Kluwer Health
+1 (781) 392-2411
andre.rebelo@wolterskluwer.com

More News From Wolters Kluwer Health

Wolters Kluwer report: unified and proactive care that addresses social drivers of health can help reduce cardiovascular disease

WALTHAM, Mass.--(BUSINESS WIRE)--Wolters Kluwer Health released a new report outlining how healthcare leaders can help drive better patient outcomes for cardiovascular health....

Wolters Kluwer Survey: Over Two-Thirds of U.S. Physicians Have Changed Their Mind, Now Viewing GenAI as Beneficial in Healthcare

WALTHAM, Mass.--(BUSINESS WIRE)--A Wolters Kluwer Health survey finds 68% of U.S. physicians changed views in the last year, now more likely view GenAI as beneficial to healthcare....

Wolters Kluwer supports Brazil with access to trusted medical content on Dengue disease

SÃO PAULO--(BUSINESS WIRE)--With the significant growth of Dengue cases in Brazil, Wolters Kluwer Health is providing free, online access to evidence-based information about the disease from its clinical decision support (CDS) resource, UpToDate. Access is available to doctors, even if they are not UpToDate subscribers, as well as to the general community by visiting this link. According to data from the Brazilian Ministry of Health, by the second week of March 2024, more than 1.3 million proba...
Back to Newsroom